Company: HCWB
Filing Date: 2025-02-21
Form Type: DEF 14A
Source: 0001193125-25-032115
Chunk: 41

Company: HCW Biologics Inc.
Filing Date: 2025-02-21
Form: DEF 14A
Chunk 41
---
 the meaning specified in
.

“” shall mean Regulation D promulgated under the Securities Act.

“” shall mean Rule 144 promulgated under the Securities Act or any similar provision then in force under the
Securities Act.

“” or “Commission” shall mean the United States Securities and Exchange Commission.

“” shall have the meaning specified in .

“” means, collectively, the Put Shares and the Commitment Shares.

- A-4 -

“” shall mean the Securities Act of 1933, as amended.

“” means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock
Market (or any successor entity), including, without limitation Rule 5635, from the stockholders of the Company, or board of directors in lieu thereof, with respect to issuance of the Put Shares in excess of 19.99% of the Company’s outstanding
shares.

“” shall mean all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange
Act or any hedging transaction that establishes a net short position with respect to the Common Stock.

“” or
“” means any Person the Company wholly-owns or controls, or in which the Company, directly or indirectly, owns a majority of the voting stock or similar voting interest, in each case that would be disclosable pursuant to
Item 601(b)(21) of Regulation S-K promulgated under the Securities Act.

“” shall have the meaning specified in .

“” means any
full trading day (beginning at 9:30:01 a.m., New York City time, and ending at 4:00 p.m., New York City time) on the Principal Market or, if the Common Stock is then listed on an Eligible Market, on such Eligible Market.

“” shall mean this Agreement, the Registration Rights Agreement, the Transfer Agent Instruction Letter,
and all schedules and exhibits hereto and thereto.

“” shall mean Equiniti Trust Company, LLC, the current
transfer agent of the Company, and any successor transfer agent of the Company.

“”
means the letter from the Company to the Transfer Agent which instructs the Transfer Agent to issue the Put Shares and the Commitment Shares pursuant to the Transaction Documents, in the form of attached hereto.

“” shall mean the period of three (3) consecutive Trading Days immediately following the applicable Put
Date.

“” means, for the Common Stock as of any Trading Day, the dollar volume